company coverage
ECHOIQ LIMITED research (ASX:EIQ)
Coverage of ECHOIQ LIMITED collects dated research on business quality, return drivers, balance-sheet resilience, valuation scenarios, and what would change the thesis for ASX:EIQ.
1 edition linked in this hub.
Coverage
- 9 Sept 2026An unpublished FDA letter now controls Echo IQ's heart-failure timetableEcho IQ (ASX:EIQ) fell 50% after the FDA rejected EchoSolv HF's 510(k). The remaining valuation still assumes a regulatory recovery.